The identification of the HMMR/MAP4K4/p-c-JUN/MMP1 signaling axis provides new insights into NSCLC metastasis and could inform future therapeutic strategies aimed at inhibiting NSCLC progression. The gene discussed is MAP4K4; the disease is non-small cell lung carcinoma.